Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Section Editors
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
ANESTHESIOLOGY / CLINICAL RESEARCH
Efficacy of goal-directed fluid therapy monitored by pulse-pressure variation using a continuous noninvasive arterial pressure monitoring system (the CNAPTM system) during parathyroidectomy in patients with end-stage renal failure – a randomised trial
1
Department of Anaesthesiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Submission date: 2019-10-11
Final revision date: 2020-04-17
Acceptance date: 2020-04-28
Online publication date: 2020-05-18
Publication date: 2026-01-16
Corresponding author
Jie Song
Department of Anaesthesiology Second Affiliated Hospital Anhui Medical University Hefei, Anhui, China
Department of Anaesthesiology Second Affiliated Hospital Anhui Medical University Hefei, Anhui, China
Arch Med Sci 2025;21(6):2414-2425
KEYWORDS
TOPICS
ABSTRACT
Introduction:
There are no well-recognised guidelines for intraoperative fluid management in patients with end-stage renal failure (ESRF). Goal-directed fluid therapy (GDFT) is a concept of perioperative fluid management that improves patients’ prognosis. In this study, we assessed a GDFT protocol with monitoring of pulse pressure variation (PPV) in patients with ESRF undergoing parathyroidectomy.
Material and methods:
A total of 102 patients who underwent elective parathyroidectomy were randomised into a control group (restrictive group, n = 51), managed with a restricted fluid regimen, or a PPV group (GDFT group, n = 51), given a normal saline infusion, and they were monitored for changes in PPV. If PPV reached > 13%, 250 ml of normal saline was administered over 15 min. Ephedrine was given to keep the mean arterial pressure > 65 mm Hg. Haemodynamic variables in the perioperative period were recorded. The primary endpoint was the occurrence of postoperative hypotension.
Results:
The occurrence of postoperative hypotension (0 vs. 11.67%, p = 0.027) and complications (35.3% vs. 54.9%, p = 0.047) in the GDFT group was lower than in the restrictive group. The volume of saline infused during the operation was 364 (219–408) ml and 50 (50–50) ml, respectively (p = 0.001). Ephedrine was given to 16/51 (29.4%) patients of the GDFT group and 27/51 (52.9%) patients of the restrictive group (p = 0.027).
Conclusions:
The use of GDFT with dynamic PPV monitoring in patients with ESRF undergoing parathyroidectomy could potentially be used to guide the administration of infused fluids, with the possibility of reducing the occurrence of postoperative hypotension.
There are no well-recognised guidelines for intraoperative fluid management in patients with end-stage renal failure (ESRF). Goal-directed fluid therapy (GDFT) is a concept of perioperative fluid management that improves patients’ prognosis. In this study, we assessed a GDFT protocol with monitoring of pulse pressure variation (PPV) in patients with ESRF undergoing parathyroidectomy.
Material and methods:
A total of 102 patients who underwent elective parathyroidectomy were randomised into a control group (restrictive group, n = 51), managed with a restricted fluid regimen, or a PPV group (GDFT group, n = 51), given a normal saline infusion, and they were monitored for changes in PPV. If PPV reached > 13%, 250 ml of normal saline was administered over 15 min. Ephedrine was given to keep the mean arterial pressure > 65 mm Hg. Haemodynamic variables in the perioperative period were recorded. The primary endpoint was the occurrence of postoperative hypotension.
Results:
The occurrence of postoperative hypotension (0 vs. 11.67%, p = 0.027) and complications (35.3% vs. 54.9%, p = 0.047) in the GDFT group was lower than in the restrictive group. The volume of saline infused during the operation was 364 (219–408) ml and 50 (50–50) ml, respectively (p = 0.001). Ephedrine was given to 16/51 (29.4%) patients of the GDFT group and 27/51 (52.9%) patients of the restrictive group (p = 0.027).
Conclusions:
The use of GDFT with dynamic PPV monitoring in patients with ESRF undergoing parathyroidectomy could potentially be used to guide the administration of infused fluids, with the possibility of reducing the occurrence of postoperative hypotension.
REFERENCES (41)
1.
Joosten A, Huynh T, Suehiro K, Canales C, Cannesson M, Rinehart J. Goal-directed fluid therapy with closed-loop assistance during moderate risk surgery using noninvasive cardiac output monitoring: a pilot study. Br J Anaesth 2015; 114: 886-92.
2.
Joosten A, Coeckelenbergh S, Delaporte A, et al. Implementation of closed-loop-assisted intra-operative goal-directed fluid therapy during major abdominal surgery: a case-control study with propensity matching. Eur J Anaesthesiol 2018; 35: 650-8.
3.
Joosten A, Delaporte A, Ickx B, et al. Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system: a randomized, double-blinded, controlled trial in major abdominal surgery. Anesthesiology 2018; 128: 55-66.
4.
Joosten A, Hafiane R, Pustetto M, et al. Practical impact of a decision support for goal-directed fluid therapy on protocol adherence: a clinical implementation study in patients undergoing major abdominal surgery. J Clin Monit Comput 2019; 33: 15-24.
5.
Joosten A, Raj Lawrence S, Colesnicenco A, et al. Personalized versus protocolized fluid management using noninvasive hemodynamic monitoring (Clearsight System) in patients undergoing moderate-risk abdominal surgery. Anesth Analg 2019; 129: e8-12.
6.
Edwards MR, Forbes G, MacDonald N, et al. Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery. BMJ Open 2019; 9: e023455.
7.
Miller TE, Pearse RM. Perioperative fluid management: moving toward more answers than questions-a commentary on the RELIEF study. Perioper Med (Lond) 2019; 8: 2.
8.
Ishani A, Liu J, Wetmore JB, et al. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clin J Am Soc Nephrol 2015; 10: 90-7.
9.
Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int 2000; 58: 2147-54.
10.
Santos JF, Parreira L, Madeira J, Fonseca N, Soares LN, Ines L. Non invasive hemodynamic monitorization for AV interval optimization in patients with ventricular resynchronization therapy. Rev Port Cardiol 2003; 22: 1091-8.
11.
Lindberg M, Prutz KG, Lindberg P, Wikstrom B. Interdialytic weight gain and ultrafiltration rate in hemodialysis: lessons about fluid adherence from a national registry of clinical practice. Hemodial Int 2009; 13: 181-8.
12.
Mambelli E, Mancini E, Santoro A. A continuous and non-invasive arterial pressure monitoring system in dialysis patients. Nephron Clin Pract 2007; 107: c170-6.
13.
Rollins KE, Lobo DN. Intraoperative goal-directed fluid therapy in elective major abdominal surgery: a meta-analysis of randomized controlled trials. Ann Surg 2016; 263: 465-76.
14.
Nazemi M, Raad MH, Arzoomanian CS, Ghasemzadeh A. Fatigue and depression in iranian amyotrophic lateral sclerosis patients in Tehran in 2012. Electron Physician 2016; 8: 2194-8.
15.
Oltmann SC, Madkhali TM, Sippel RS, Chen H, Schneider DF. Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism. J Surg Res 2015; 199: 115-20.
16.
Marik PE. Noninvasive cardiac output monitors: a state-of the-art review. J Cardiothorac Vasc Anesth 2013; 27: 121-34.
17.
Yuen NK, Ananthakrishnan S, Campbell MJ. Hyperparathyroidism of Renal Disease. Perm J 2016; 20: 15-27.
18.
Corneci M, Stanescu B, Trifanescu R, et al. Perioperative management difficulties in parathyroidectomy for primary versus secondary and tertiary hyperparathyroidism. Maedica (Buchar) 2012; 7: 117-24.
19.
Smith GE, Gohil R, Chetter IC. Factors affecting the patency of arteriovenous fistulas for dialysis access. J Vasc Surg 2012; 55: 849-55.
20.
Khan A, Khan AH, Adnan AS, Syed Sulaiman SA, Gan SH, Khan I. Management of patient care in hemodialysis while focusing on cardiovascular disease events and the atypical role of hyper- and/or hypotension: a systematic review. Biomed Res Int 2016; 2016: 9710965.
21.
Minto G, Mythen MG. Perioperative fluid management: science, art or random chaos? Br J Anaesth 2015; 114: 717-21.
22.
Ackland GL, Moran N, Cone S, Grocott MP, Mythen MG. Chronic kidney disease and postoperative morbidity after elective orthopedic surgery. Anesth Analg 2011; 112: 1375-81.
23.
Nissen P, Brassard P, Jorgensen TB, Secher NH. Phenylephrine but not ephedrine reduces frontal lobe oxygenation following anesthesia-induced hypotension. Neurocrit Care 2010; 12: 17-23.
24.
Meersch M, Schmidt C, Zarbock A. Patient with chronic renal failure undergoing surgery. Curr Opin Anaesthesiol 2016; 29: 413-20.
25.
Sessler DI, Khanna AK. Perioperative myocardial injury and the contribution of hypotension. Intensive Care Med 2018; 44: 811-22.
26.
van Waes JA, van Klei WA, Wijeysundera DN, van Wolfswinkel L, Lindsay TF, Beattie WS. Association between intraoperative hypotension and myocardial injury after vascular surgery. Anesthesiology 2016; 124: 35-44.
27.
Salmasi V, Maheshwari K, Yang D, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology 2017; 126: 47-65.
28.
Bennett VA, Cecconi M. Perioperative fluid management: from physiology to improving clinical outcomes. Indian J Anaesth 2017; 61: 614-21.
29.
Voldby AW, Brandstrup B. Fluid therapy in the perioperative setting-a clinical review. J Intensive Care 2016; 4: 27.
30.
Craig RG, Hunter JM. Recent developments in the perioperative management of adult patients with chronic kidney disease. Br J Anaesth 2008; 101: 296-310.
31.
Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol 2003; 93: 94-101.
32.
Peralta CA, Shlipak MG, Wassel-Fyr C, et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension 2007; 50: 474-80.
33.
Kanda H, Hirasaki Y, Iida T, et al. Perioperative management of patients with end-stage renal disease. J Cardiothorac Vasc Anesth 2017; 31: 2251-67.
34.
Stenglova A, Benes J. Continuous non-invasive arterial pressure assessment during surgery to improve outcome. Front Med (Lausanne) 2017; 4: 202.
35.
Wimmer J, Batzel JJ, Haditsch B, Schneditz D. Evolution of volume sensitivity during hemodialysis and ultrafiltration. Clin Auton Res 2011; 21: 353-60.
36.
Jeleazcov C, Krajinovic L, Munster T, et al. Precision and accuracy of a new device (CNAPTM) for continuous non-invasive arterial pressure monitoring: assessment during general anaesthesia. Br J Anaesth 2010; 105: 264-72.
37.
Yoshii M, Minami J, Ishimitsu T, Yamakoshi K, Matsuoka H. Non-invasive monitoring of hemodynamic changes during hemodialysis by the use of a newly developed admittance cardiograph. Ther Apher Dial 2005; 9: 154-60.
38.
Michard F. Changes in arterial pressure during mechanical ventilation. Anesthesiology 2005; 103: 419-28.
39.
Monnet X, Dres M, Ferre A, et al. Prediction of fluid responsiveness by a continuous non-invasive assessment of arterial pressure in critically ill patients: comparison with four other dynamic indices. Br J Anaesth 2012; 109: 330-8.
40.
Marik PE. Fluid responsiveness and the six guiding principles of fluid resuscitation. Crit Care Med 2016; 44: 1920-2.
41.
Biais M, Stecken L, Martin A, Roullet S, Quinart A, Sztark F. Automated, continuous and non-invasive assessment of pulse pressure variations using CNAP((R)) system. J Clin Monit Comput 2017; 31: 685-92.
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
